Vitro Diagnostics (VODG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Sales | 1,856 | 1,764 | 3,293 | 1,311 | 649 |
| Cost of Goods | 426 | 298 | 587 | 351 | 217 |
| Gross Profit | 1,430 | 1,465 | 2,706 | 960 | 432 |
| Operating Expenses | 11,009 | 7,145 | 9,260 | 5,428 | 1,917 |
| Operating Income | -9,153 | -5,382 | -5,966 | -4,117 | -1,269 |
| Interest Expense | 4,243 | 270 | 199 | 405 | 294 |
| Other Income | 3,522 | 295 | -695 | 0 | 0 |
| Pre-tax Income | -9,874 | -5,357 | -6,860 | -4,522 | -1,563 |
| Net Income Continuous | -9,874 | -5,357 | -6,860 | -4,522 | -1,563 |
| Net Income | $-9,874 | $-5,357 | $-6,860 | $-4,522 | $-1,563 |
| EPS Basic Total Ops | -2.21 | -1.21 | -1.87 | -0.09 | -0.04 |
| EPS Basic Continuous Ops | -2.21 | -1.21 | -1.66 | -0.08 | -0.03 |
| EPS Diluted Total Ops | -2.21 | -1.21 | -1.87 | -0.09 | -0.04 |
| EPS Diluted Continuous Ops | -2.21 | -1.21 | -1.66 | -0.08 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -2.21 | -1.21 | N/A | N/A | N/A |
| EBITDA(a) | $-4,826 | $-4,984 | $-5,615 | $-3,764 | $-964 |